Nelarabine Injection
Product Images NDC 62332-813

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 62332-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nelarabine-carton-1s-pack (Nelarabine Carton 1s Pack)

This is a prescription drug label for Nelarabine Injection containing 250 mg/50 mL. The medication should be administered via intravenous infusion only. It is manufactured by Alembic Pharmaceuticals Limited. The product is stored between 20°C and 25°C and should not be used if the solution is cloudy or contains a precipitate. Each vial contains 5 grams of Nelarabine and must be discarded if unused. Always follow the instructions provided on the package insert for the correct dosage.*

FDA Label Image

Nelarabine-carton-6s-pack (Nelarabine Carton 6s Pack)

FDA Label Image

Nelarabine-structure (Nelarabine Structure)

FDA Label Image

Nelarabine-vial-label (Nelarabine Vial Label)

This text provides detailed information about Nelarabine Injection medication, with specifications such as dosage strength, storage conditions, manufacturer details, and usage instructions. It contains important warnings, such as discarding unused portion and not using if the vial stoppers are made of natural rubber latex. The medication is intended for intravenous infusion only. The text includes the NDC code, active and inactive ingredients, as well as a reference to the package insert for the usual dose information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.